Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. Read more about Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.
Intermittent versus continuous androgen deprivation in prostate cancer. Read more about Intermittent versus continuous androgen deprivation in prostate cancer.
The cardiovascular perils of cancer survivorship. Read more about The cardiovascular perils of cancer survivorship.
Abiraterone in metastatic prostate cancer without previous chemotherapy. Read more about Abiraterone in metastatic prostate cancer without previous chemotherapy.
Antiretroviral agents and prevention of malaria in HIV-infected Ugandan children. Read more about Antiretroviral agents and prevention of malaria in HIV-infected Ugandan children.
Clinical decisions. Mammography screening for breast cancer. Read more about Clinical decisions. Mammography screening for breast cancer.
Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. Read more about Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations.
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. Read more about Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Lenalidomide after stem-cell transplantation for multiple myeloma. Read more about Lenalidomide after stem-cell transplantation for multiple myeloma.
